PCS
ABMD

Personal CFO Solutions’s Abiomed Inc ABMD Stock Holding History

Personal CFO Solutions’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-708
Closed -$235K – 508
2022
Q1 		$235K Buy
+708
New +$218K 0.05% 398

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Personal CFO Solutions's ABMD Position: Q2 2022 in Review

Personal CFO Solutions sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 708 shares — an estimated $235K sold.

Personal CFO Solutions first reported a position in ABMD in Q1 2022 and held it in 1 quarter. The position peaked at $235K in Q1 2022. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

  • Personal CFO Solutions reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
  • Personal CFO Solutions sold 708 Abiomed Inc shares in Q2 2022, an estimated $235K.
  • Personal CFO Solutions first reported a position in Abiomed Inc in Q1 2022 and held it in 1 quarter.
  • Personal CFO Solutions's Abiomed Inc position peaked at $235K in Q1 2022.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on Personal CFO Solutions's 13F filing for Q2 2022, filed 5 Aug 2022.